Back to search results

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE1

Conditions

B-cell Malignancy · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Waldenstrom Macroglobulinemia · Mantle Cell Lymphoma · Marginal Zone Lymphoma · Follicular Lymphoma · Non-Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UC Irvine Health, Orange, California, United States

    Contact: Study coordinator (Catherine Coombs, MD) · ucstudy@hs.uci.edu · 714-456-8000
    Contact: Principal Investigator (Catherine Coombs, MD)

  • Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States

    Contact: Study coordinator (Yvonne Enriquez) · yvonne.enriquez@msmc.com · 305-674-2625
    Contact: Principal Investigator (Jacqueline Barrientos, MD)

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Richard Corona) · richard.corona@moffitt.org · (813) 745-3465
    Contact: Principal Investigator (Javier Pinilla-Ibarz, MD PhD)

  • Northwestern Memorial Hospital, Chicago, Illinois, United States

    Contact: Study coordinator (Study Cordinator) · cancer@northwestern.edu · (312) 695 1301
    Contact: Principal Investigator (Shuo Ma, MD PhD)

  • American Oncology Partners, Fort Wayne, Indiana, United States

    Contact: Study coordinator (Phil Hutson) · phil.hutson@aoncology.com · 260-312-2219
    Contact: Principal Investigator (Sunil Babu, MD)

  • University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Nikki M Glynn-Cunningham, MS) · nglynn@umm.edu · 410-328-7996
    Contact: Principal Investigator (Seung Tae Lee, MD PhD)

  • University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

    Contact: Study coordinator (UMass Cancer Research Office) · cancer.research@umassmed.edu · 508-856-3216
    Contact: Principal Investigator (Andrew J Gillis-Smith, MD)

  • Optum Medical Care PC, Westbury, New York, United States

    Contact: Study coordinator (Jonathan Goldberg, MD) · jgoldberg@caremount.com · 914-241-1050
    Contact: Principal Investigator (Jonathan Goldberg, MD)

  • Duke University, Durham, North Carolina, United States

    Contact: Study coordinator (Terri Lucas) · terri.lucas@duke.edu · 919-681-6580
    Contact: Principal Investigator (Danielle Brander, MD)

  • Taylor Cancer Research Center, Maumee, Ohio, United States

    Contact: Study coordinator (Nadine Nemunaitis) · nnemunaitis@tcrcpt.org · 567-402-4501
    Contact: Principal Investigator (John Nemunaitis, MD)

  • Oncology Consultants, Houston, Texas, United States

    Contact: Study coordinator (Laura Guerra, RN, CCRC) · lguerra@oncologyconsultants.com · 713-516-4968
    Contact: Study coordinator (Marisol Dominguez) · mdominguez@oncologyconsultants.com · 832-333-1480
    Contact: Principal Investigator (Julio A Peguero, MD)

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Nitin Jain, MD) · njain@mdanderson.org · 713-745-6080
    Contact: Principal Investigator (Nitin Jain, MD)

  • The Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Medical College of Wisconsin Cancer Center Clinical Trials Office) · cccto@mcw.edu · 414-805-8900
    Contact: Principal Investigator (Nirav Shah, MD)
View source on ClinicalTrials.gov(opens in a new tab)